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Complex I, the main entry point for electrons to the respiratory chain, is of critical importance for cellular
energy homeostasis. In this issue of Cell Metabolism, Kruse and coworkers (2008) describe the first mouse
knockout for a complex I structural subunit, thus advancing our understanding of complex I in disease.The oxidative phosphorylation system
consists of five enzyme complexes (com-
plexes I–V) that produce ATP, the energy
currency driving a variety of metabolic re-
actions in cells. Electrons harvested from
intermediary metabolism enter the respi-
ratory chain (complexes I–IV) and are
transferred to oxygen after a series of
coupled redox reactions. Energy from
this sequential electron transfer creates
a proton gradient across the inner mito-
chondrial membrane, which drives the
ATP synthase (complex V). Impaired oxi-
dative phosphorylation may have fatal
consequences in the case of mitochon-
drial disease and has also been impli-
cated in common age-associated dis-
eases, e.g., Parkinson’s disease, as well
as normal aging (Trifunovic and Larsson,
2008). In this issue of Cell Metabolism,
a study by Kruse et al. (2008) starts ad-
dressing the role of complex I in disease.
Complex I (NADH:ubiquinone oxidore-
ductase) is the main gateway for electron
entry to the respiratory chain. It forms an
L-shaped structure with a hydrophobic
arm embedded in the inner mitochondrial
membrane and a hydrophilic arm protrud-
ing into the matrix (Figure 1). Determina-
tion of the structure of the hydrophilic
arm of bacterial complex I has shown
that it contains all of the components
needed for electron translocation (Saza-
nov, 2007). Bacterial complex I contains
13–15 subunits, whereas the mammalian
enzyme contains at least 45 subunits, 7
of which are encoded by mitochondrial
DNA (mtDNA) and the rest by nuclear
DNA. Most of the mammalian complex I
subunits lack bacterial homologs, and
their function is poorly understood. It has
been suggested that they may insulate
against electron escape and thus prevent
the formation of reactive oxygen species
(ROS) or that they may have a role in278 Cell Metabolism 7, April 2008 ª2008 Elseassembling or stabilizing the assembled
complex.
Complex I deficiency is a common bio-
chemical defect in patients with mito-
chondrial disorders and may be caused
by mutations of either nuclear-encoded
or mtDNA-encoded subunits (Janssen
et al., 2006). A few cases with complex I
deficiency caused bymutations in nuclear
genes encoding assembly factors have
also been described (Dunning et al., 2007;
Vogel et al., 2007). The clinical manifesta-
tions of complex I deficiency are highly
variable, and the severity of disease
ranges from mild to fatal (Janssen et al.,
2006). Carriers of mtDNAmutations caus-
ing Leber’s hereditary optic neuropathy
(LHON) have a systemic complex I defi-
ciency, but only a subset of these individ-
uals develop optic neuropathy and some-
times additional symptoms (Janssen
et al., 2006). In contrast, othermtDNAmu-
tations affecting genes encoding complex
I subunits cause severe phenotypes such
as neonatal lactic acidosis, failure to
thrive, cardiomyopathy, myopathy, or en-
cephalopathy (Janssen et al., 2006; Estei-
tie et al., 2005). Similar symptoms, often
presenting in the neonatal period, are
found in complex I deficiencies caused
by nuclear mutations (Janssen et al.,
2006). A common pathological finding in
children with complex I deficiency is
necrotizing degeneration of the basal
ganglia, a condition known as Leigh syn-
drome, as exemplified by patients born
with loss-of-function mutations in the
nuclear NDUFS4 complex I subunit gene
(Petruzzella et al., 2001). The large num-
ber of complex I subunits and the highly
variable phenotypes associated with com-
plex I deficiency necessitate a systematic
approach to better understand the role
of each subunit and to explain the geno-
type-phenotype connections.vier Inc.Kruse et al. (2008) have now knocked
out one of these structural subunits,
Ndufs4, in the mouse to generate the first
mouse model with isolated complex I de-
ficiency. Surprisingly, a severe complex I
deficiency was compatible with normal
development, as germline homozygous
knockouts were viable and appeared
healthy at birth. However, the complex
I-deficient mice rapidly deteriorated in the
postnatal period and became lethargic,
developed ataxia, lost weight, and finally
died at 5–7 weeks of age. This pheno-
type has similarities with the severe neu-
rological symptoms and early death
seen in NDUFS4-deficient patients (Pet-
ruzzella et al., 2001) but does not include
significant lactic acidosis or severe neu-
rodegeneration. The authors report that
conditional knockout mice with disrup-
tion of Ndufs4 in neurons have a pheno-
type similar to the homozygous germline
knockout mice, suggesting that the ner-
vous system is more vulnerable to com-
plex I deficiency than other organs.
The clinical manifestations and severity
of disease in complex I-deficient humans
correlate poorly with genotype and resid-
ual enzyme activity. This enigma remains
unresolved; possible explanations in-
clude the following: (1) Certain complex I
subunits likely have a direct role in sus-
taining particular enzymatic activities,
e.g., electron transport, proton transloca-
tion, or other as yet unknown processes.
(2) Some complex I subunits are likely
critical for assembling or stabilizing the
assembled complex. Several disease-
causing mutations in humans (Petruzzella
et al., 2001; Vogel et al., 2007) andNdufs4
gene disruption inmice (Kruse et al., 2008)
lead to reduced levels of assembled
complex I. (3) Impaired function of com-
plex I may alter cellular NADH/NAD+
levels and thereby cause deregulation of
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PreviewsFigure 1. Complex I in Health and Disease
Complex I forms an L-shaped structure embedded in the inner mitochondrial membrane. The peripheral
arm binds NADH, and electrons are transferred through flavin mononucleotide (FMN) and a chain of at
least eight iron-sulfur (FeS) clusters (red circles) before being delivered to ubiquinone (coenzyme Q; Q)
to form ubiquinol (QH2) for further shuttling of electrons to complex III. The first iron-sulfur cluster (con-
nected by dotted lines) is not aligned in the path of the electron flow and has been suggested to have
a function in preventing formation of reactive oxidative species (Sazanov, 2007). The mechanismwhereby
electron translocation by the peripheral arm creates proton pumping by the membrane component is
unknown. Complex I deficiency causes a variety of clinical manifestations such as encephalopathy, optic
atrophy, cardiomyopathy, and myopathy.intermediary metabolism. Complex I-defi-
cient patients often display secondary
effects on the citric acid cycle leading to
decreased inhibition of complex II and
increased succinate oxidation (Esteitie
et al., 2005). (4) Increased production of
ROS has been proposed to be of impor-
tance, but there is not much experimental
support for this mechanism. In fact, mice
with generalized respiratory chain defi-
ciency and patients with different typesof mitochondrial diseases generally do
not have increased ROS production
(Trifunovic and Larsson, 2008). Disruption
of the gene encoding apoptosis-inducing
factor (AIF) in mice causes respiratory
chain deficiency, mainly affecting com-
plex I, but no increase in ROS production
(Pospisilik et al., 2007). Also, the Ndufs4
knockout mice exhibited no increase in
ROS production (Kruse et al., 2008). (5) Fi-
nally, it should be mentioned that mtDNACell Metabmutations causing complex I deficiency
often are heteroplasmic, and different tis-
sues therefore often have different gene
dosages of the disease-causing mutation
(Smeitink et al., 2006).
Clearly, much remains to be learned
about the downstream effects of inherited
andacquiredcomplex I deficiency.Mouse
models, like the Ndufs4 knockout mouse,
will be invaluable tools for understanding
the role of complex I in normal physiology
and disease.
REFERENCES
Dunning, C.J.R., McKenzie, M., Sugiana, C., Laz-
arou, M., Silke, J., Connelly, A., Fletcher, J.M.,
Kirby, D.M., Thorburn, D.R., and Ryan, M.T.
(2007). EMBO J. 26, 3227–3237.
Esteitie, N., Hinttala, R., Wibom, R., Nilsson, H.,
Hance, N., Naess, K., Tea¨r-Fahnehjelm, K., von
Do¨beln, U., Majamaa, K., and Larsson, N.G.
(2005). Ann. Neurol. 58, 544–552.
Janssen, R.J., Nijmans, L.G., van den Heuwel,
L.P., and Smeitink, J.A.M. (2006). J. Inherit. Metab.
Dis. 29, 499–515.
Kruse, S.E., Watt, W.C., Marcinek, D.J., Kapur,
R.P., Schenkman, K.A., and Palmiter, R.D. (2008).
Cell Metab. 7, this issue, 312–320.
Petruzzella, V., Vergari, R., Puzziferri, I., Boffoli, D.,
Lamantea, E., Zeviani, M., and Papa, S. (2001).
Hum. Mol. Genet. 10, 529–535.
Pospisilik, J.A., Knauf, C., Joza, N., Benit, P.,
Orthofer, M., Cani, P.D., Ebersberger, I., Naka-
shima, T., Sarao, R., Neely, G., et al. (2007). Cell
131, 476–491.
Sazanov, L.A. (2007). Biochemistry 46, 2275–2288.
Smeitink, J.A.M., Zeviani, M., Turnbull, D.M., and
Jacobs, H.T. (2006). Cell Metab. 3, 9–13.
Trifunovic, A., and Larsson, N.G. (2008). J. Intern.
Med. 263, 167–178.
Vogel, R.O., Smeitink, J.A.M., and Nijtmans, L.G.J.
(2007). Biochim. Biophys. Acta 1767, 1215–1227.olism 7, April 2008 ª2008 Elsevier Inc. 279
